102 related articles for article (PubMed ID: 29350496)
1. Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1.
Mauro M; Saggiorato G; Sartori MT; Gallo G; De Bortoli M; Bonetti E; Zaccaron A; Vitale V; Balter R; Chinello M; Cesaro S
Pediatr Blood Cancer; 2018 Jun; 65(6):e26963. PubMed ID: 29350496
[TBL] [Abstract][Full Text] [Related]
2. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
[TBL] [Abstract][Full Text] [Related]
3. Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia.
Papadopoulos A; Ntaios G; Kaiafa G; Girtovitis F; Saouli Z; Kontoninas Z; Diamantidis MD; Savopoulos C; Hatzitolios A
Int J Hematol; 2008 Nov; 88(4):441-442. PubMed ID: 18839274
[TBL] [Abstract][Full Text] [Related]
4. Sinusoidal Obstruction Syndrome During Chemotherapy of Pediatric Cancers and its Successful Management With Defibrotide.
Kizilocak H; Dikme G; Özdemir N; Kuruğoğlu S; Adaletli İ; Erkan T; Celkan T
J Pediatr Hematol Oncol; 2017 Oct; 39(7):e373-e376. PubMed ID: 28859028
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.
Giordano P; Molinari AC; Del Vecchio GC; Saracco P; Russo G; Altomare M; Perutelli P; Crescenzio N; Santoro N; Marchetti M; De Mattia D; Falanga A
Am J Hematol; 2010 May; 85(5):325-30. PubMed ID: 20425794
[TBL] [Abstract][Full Text] [Related]
6. Veno-occlusive disease in pediatric patients affected by Wilms tumor.
Cesaro S; Spiller M; Sartori MT; Alaggio R; Peruzzo M; Saggiorato G; Bisogno G
Pediatr Blood Cancer; 2011 Aug; 57(2):258-61. PubMed ID: 21246705
[TBL] [Abstract][Full Text] [Related]
7. Sinusoidal Obstruction Syndrome During Maintenance Therapy for Acute Lymphoblastic Leukemia With 6-Mercaptopurine and Methotrexate: A Pediatric Case Report.
McNerney KO; Vasquez JC; Kent MW; McNamara JM
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e454-e455. PubMed ID: 28085749
[TBL] [Abstract][Full Text] [Related]
8. New insights into sinusoidal obstruction syndrome.
Piccin A; Sartori MT; Bisogno G; Van Schilfgaarde M; Saggiorato G; Pierro AMD; Corvetta D; Marcheselli L; Mega A; Gastl G; Cesaro S
Intern Med J; 2017 Oct; 47(10):1173-1183. PubMed ID: 28707749
[TBL] [Abstract][Full Text] [Related]
9. Sinusoidal obstruction syndrome during induction therapy for acute lymphoblastic leukemia managed with N-acetyl Cysteine.
Sahoo RK; Sharma A
Pediatr Blood Cancer; 2011 Oct; 57(4):700. PubMed ID: 21656901
[No Abstract] [Full Text] [Related]
10. DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemia.
Toksvang LN; Grell K; Nielsen SN; Nersting J; Murdy D; Moorman AV; Vora A; Schmiegelow K
Leukemia; 2022 Feb; 36(2):555-557. PubMed ID: 34535761
[No Abstract] [Full Text] [Related]
11. [Usefulness of serum plasminogen activator inhibitor-1 for diagnosis and monitoring of late-onset sinusoidal obstruction syndrome after allogeneic stem cell transplantation].
Ito S; Taguchi J; Kato J; Nakaya A; Tachibana T; Takemura S; Sano A; Ohata M; Ishigatsubo Y; Fujita H
Rinsho Ketsueki; 2010 Jan; 51(1):69-73. PubMed ID: 20134143
[TBL] [Abstract][Full Text] [Related]
12. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
13. Clinical severe hepatic venoocclusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide.
Bairey O; Kirgner I; Yakobi M; Hamdan A; Ben-Ari Z; Shaklai M
Am J Hematol; 2002 Apr; 69(4):281-4. PubMed ID: 11921023
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
15. Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia.
Stanulla M; Schaeffeler E; Möricke A; Buchmann S; Zimmermann M; Igel S; Schmiegelow K; Flotho C; Hartmann H; Illsinger S; Sauerbrey A; Junk SV; Schütte P; Hinze L; Lauten M; Modlich S; Kolb R; Rossig C; Schwabe G; Gnekow AK; Fleischhack G; Schlegel PG; Schünemann HJ; Kratz CP; Cario G; Schrappe M; Schwab M
Leukemia; 2021 Sep; 35(9):2650-2657. PubMed ID: 33714975
[TBL] [Abstract][Full Text] [Related]
16. PAI-1 and protein C as early markers of veno-occlusive disease in patients treated for Wilms tumor.
Cesaro S; Mauro M; Sattin G; Sartori MT; Saggiorato G; Paratella A; Tridello G; Bisogno G
Pediatr Blood Cancer; 2019 Jul; 66(7):e27695. PubMed ID: 30865371
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia.
Bond J; Adams S; Richards S; Vora A; Mitchell C; Goulden N
Blood; 2011 Sep; 118(9):2632-3. PubMed ID: 21885611
[No Abstract] [Full Text] [Related]
18. Phosphodiesterase III inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse's space.
Miyata T; Tajima H; Hirata M; Nakanuma SI; Makino I; Hayashi H; Oyama K; Miyashita T; Takamura H; Ninomiya I; Fushida S; Iseki S; Harada SI; Wakayama T; Ohta T
J Gastroenterol Hepatol; 2018 Apr; 33(4):950-957. PubMed ID: 28960464
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia.
Place AE; Pikman Y; Stevenson KE; Harris MH; Pauly M; Sulis ML; Hijiya N; Gore L; Cooper TM; Loh ML; Roti G; Neuberg DS; Hunt SK; Orloff-Parry S; Stegmaier K; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2018 Jul; 65(7):e27062. PubMed ID: 29603593
[TBL] [Abstract][Full Text] [Related]
20. Role of plasminogen activator inhibitor-1 (PAI-1) levels in the diagnosis of BMT-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF).
Kaleelrahman M; Eaton JD; Leeming D; Bowyer K; Taberner D; Chang J; Scarffe JH; Chopra R
Hematology; 2003 Apr; 8(2):91-5. PubMed ID: 12745658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
